Defective Mineralization in X-Linked Hypophosphatemia Dental Pulp Cell Cultures

J Dent Res. 2018 Feb;97(2):184-191. doi: 10.1177/0022034517728497. Epub 2017 Sep 7.

Abstract

X-linked hypophosphatemia (XLH) is a skeletal disease caused by inactivating mutations in the PHEX gene. Mutated or absent PHEX protein/enzyme leads to a decreased serum phosphate level, which cause mineralization defects in the skeleton and teeth (osteomalacia/odontomalacia). It is not yet altogether clear whether these manifestations are caused solely by insufficient circulating phosphate availability for mineralization or also by a direct, local intrinsic effect caused by impaired PHEX activity. Here, we evaluated the local role of PHEX in a 3-dimensional model of extracellular matrix (ECM) mineralization. Dense collagen hydrogels were seeded either with human dental pulp cells from patients with characterized PHEX mutations or with sex- and age-matched healthy controls and cultured up to 24 d using osteogenic medium with standard phosphate concentration. Calcium quantification, micro-computed tomography, and histology with von Kossa staining for mineral showed significantly lower mineralization in XLH cell-seeded scaffolds, using nonparametric statistical tests. While apatitic mineralization was observed along collagen fibrils by electron microscopy in both groups, Raman microspectrometry indicated that XLH cells harboring the PHEX mutation produced less mineralized scaffolds having impaired mineral quality with less carbonate substitution and lower crystallinity. In the XLH cultures, immunoblotting revealed more abundant osteopontin (OPN), dentin matrix protein 1 (DMP1), and matrix extracellular phosphoglycoprotein (MEPE) than controls, as well as the presence of fragments of these proteins not found in controls, suggesting a role for PHEX in SIBLING protein degradation. Immunohistochemistry revealed altered OPN and DMP1 associated with an increased alkaline phosphatase staining in the XLH cultures. These results are consistent with impaired PHEX activity having local ECM effects in XLH. Future treatments for XLH should target both systemic and local manifestations.

Keywords: PHEX; collagen scaffold; extracellular matrix; osteopontin; proteins; tooth.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Calcium / analysis
  • Cells, Cultured
  • Child
  • Extracellular Matrix / metabolism
  • Extracellular Matrix Proteins / metabolism
  • Familial Hypophosphatemic Rickets / genetics*
  • Genetic Diseases, X-Linked / genetics*
  • Glycoproteins / metabolism
  • Humans
  • Immunoblotting
  • Immunohistochemistry
  • Microscopy, Electron, Scanning
  • Osteopontin / metabolism
  • PHEX Phosphate Regulating Neutral Endopeptidase / genetics*
  • Phenotype
  • Phosphoproteins / metabolism
  • Polymerase Chain Reaction
  • Spectrum Analysis, Raman
  • Tissue Scaffolds
  • Tooth Demineralization / genetics*
  • Tooth, Deciduous
  • X-Ray Microtomography

Substances

  • DMP1 protein, human
  • Extracellular Matrix Proteins
  • Glycoproteins
  • MEPE protein, human
  • Phosphoproteins
  • Osteopontin
  • PHEX Phosphate Regulating Neutral Endopeptidase
  • PHEX protein, human
  • Calcium